Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola.

The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.

Inclusion Criteria:

• patient admitted to the Emergency ETC at Goderich with a clinical diagnosis of Ebola virus disease;
• patient who consent to participate in the study.

Exclusion Criteria:

• negative RT-PCR tests for Ebola virus
• age <2 years
• state of shock upon admission
• onset of fever for more than 6 days
• Glasgow Coma Scale <12
• known contraindications to administration of amiodarone
• positive for HIV antibodies.